Original Research
Accepted on 18 Jan 2024
SUBCUTANEOUS ANAKINRA IN THE MANAGEMENT OF REFRACTORY MIS-C IN FRANCE
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2024.1270878
Type at least 3 characters
166 articles
Articles
Case Report
Accepted on 08 Jan 2024
Libman-Sacks endocarditis in a child with systemic lupus erythematosus: A case report and literature review
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2024.1323943
Case Report
Published on 08 Jan 2024
A rare concomitance of Wilson’s disease and systemic lupus erythematosus in a teenage girl: a case report and literature review
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1296426
- 583 views
Case Report
Published on 08 Jan 2024
Case report: Suspected transfusion-related acute lung injury type II in a child with refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1237111
- 592 views
Case Report
Accepted on 21 Dec 2023
Case Report: Refractory Macrophage Activation Syndrome Requiring High-Dose Anakinra, Emapalumab, and Etoposide Therapy in Earlyonset Systemic Juvenile Idiopathic Arthritis Associated with Adenoviremia
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1336554
Original Research
Published on 15 Dec 2023
Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1321533
- 761 views
Case Report
Published on 13 Dec 2023
Tumor necrosis factor receptor-associated cycle syndrome: a case report and literature review
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1296487
- 666 views
Original Research
Published on 04 Dec 2023
Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1252594
- 672 views
Original Research
Published on 28 Nov 2023
Risk factors associated with multiple organ damage in childhood-onset systemic lupus erythematosus
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1301201
- 797 views
Correction
Published on 06 Nov 2023
Corrigendum: Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1323946
- 365 views
Original Research
Published on 27 Oct 2023
Remission and long-term remission of pediatric-onset systemic lupus erythematosus
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1272065
- 958 views
Original Research
Published on 21 Sep 2023
CD40 gene polymorphism and its expression in children with Kawasaki disease from North India: a preliminary case–control study and meta-analysis
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1252024
- 1,649 views
Brief Research Report
Published on 12 Sep 2023
Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1218312
- 1,819 views
Case Report
Published on 23 Aug 2023
Anti-U1RNP-70kD-positive case of neonatal lupus presenting with seizure and incomplete heart block: a case report and literature review
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1239327
- 1,259 views
Original Research
Published on 08 Aug 2023
Severe gastrointestinal involvement in pediatric IgA vasculitis: a retrospective single-center cohort study in China
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1194214
- 1,082 views
Brief Research Report
Published on 03 Aug 2023
Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America
in Pediatric Rheumatology
Frontiers in Pediatrics
doi 10.3389/fped.2023.1240242
- 1,625 views